Food and diet,
what you eat can influence
People who eat fish at least once a week have a lower risk of Alzheimer's
disease and lower risk of dementia, but only if they do not carry the gene that
increases the risk of Alzheimer's, called apolipoprotein E4, or ApoE4. Most
people do not carry the ApoE4 gene.
Eating too much sugar could be bad for your brain. Mice bred to develop an
Alzheimer's like disease that were given sugar-sweetened water had a greater
decline in learning skills and memory compared with mice that drank pure water.
The animals that consumed sugar had a greater degree of brain damage.
Natural supplements that could be of benefit

While scientists have not fully determined the actual causes of
this neurodegenerative disorder, a number of treatment options have been proposed or tried over the years. These
include: Exposure to sunlight and sleep pattern restoration. Therapy with
B vitamins
such as B6, folic acid, and B12 that lower homocysteine levels. The use of antioxidants
which could be of benefit. Providing
acetylcholine precursors such as choline
could be of benefit. Acetyl L-carnitine protects against amyloid-beta neurotoxicity
and may be helpful in combination with medicines. Providing anti-inflammatory agents such as aspirin or ibuprofen. Improve blood flow to brain cells. Mood improvement through nutrients and herbs. Use of
ginkgo biloba as a mental
enhancer. Use of
curcumin,
the yellow compound found in
turmeric, may be helpful. Mind Power Rx has acetyl
l carnitine and several brain boosting supplement.
Green tea drinking or the use of the extract pills should be considered.
Alpha lipoic acid
is an important antioxidant nutrient that can be beneficial in a number of
conditions including elevated blood sugar.
Carnosine antioxidant is
becoming more popular but it is not clear yet whether it would be helpful as an AD
treatment. Galantamine is
available as a prescription drug and also over the counter without a
prescription.
Antioxidant benefit
A German study showed alpha lipoic acid, a potent antioxidant, was
able to slow the progression. Patients with Alzheimer's disease received 600 mg of alpha lipoic
acid daily for several years. The researchers concluded that the rate of
progression of the disease was slower in comparison to normal
progression. A 600 mg dosage is quite high and we
suggest taking not more than 50 to 100 mg every other day for long term use.
Treatment of Alzheimer's Disease with a
Cholinesterase Inhibitor combined with antioxidants.
Neurodegener Dis. 2010.
Formula F was prepared to counteract oxidative stress (OS)
in the brain. The formula was
intended to) protect proteins, lipids, DNA and proteoglycans from oxidation
(carnosine, coenzyme Q10, vitamin E, vitamin C, beta-carotene, selenium, L-cysteine
and ginkgo biloba); and reduce homocysteine blood levels (vitamins B6,
B9 and B12), and (to sustain the pentose phosphate cycle in circulating
cells (vitamins B1, B2 and B3). Formula F contained low doses of each
antioxidant component. A cohort of
52 patients (21 males and 31 females) affected with moderate probable AD already
being treated with donepezil 5 mg/day for at least two months was randomly
divided into two groups, and followed for 6 months. A double-blind design was
used in which 26 cases were treated once a day with formula F plus donepezil,
and the other 26 with placebo plus donepezil. The MMSE II score remained almost the same in the group treated with donepezil and
placebo, whereas some significant improvements were found in the group treated
with donepezil plus formula F.
Fish oils, phospholipids and omega-3 fatty acid
levels
Alzheimer's research shows high fish oil intake reduces the risk for dementia.
Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and
Alzheimer disease: the Framingham Heart Study.
Arch Neurol. 2006..
Docosahexaenoic acid (DHA) is an abundant fatty acid in the brain. In the diet,
DHA is found mostly in fatty fish. The content of DHA has been shown to be
decreased in the brain and plasma of patients with dementia. To determine
whether plasma phosphatidylcholine (PC) DHA content is associated with the risk
of developing dementia. A prospective follow-up study in 899 men and women who
were free of dementia at baseline, had a median age of 76 years, and were
followed up for a mean of 9 years for the development of all-cause dementia
and Alzheimer disease. Subjects in the upper quartile of plasma PC DHA levels
had a mean DHA intake of 0.18 g/d and a mean fish intake of 3.0 servings per
week. The top quartile of plasma PC DHA level was associated with a significant reduction in the risk of developing all-cause dementia in the Framingham
Heart Study.
Herbs
Is
tongkat ali helpful as an herb for Alzheimer's dementia?
We doubt if this herb would be helpful.
Nattokinase
Do you have any information regarding using nattokinase
for Alzheimer's, ie. dissolving plaque in the brain that causes the disease.
We have not seen any research with this enzyme for
this condition.
Mental
exercises
Doing crossword puzzles and other activities to keep your mind active in old age
reduces the risk of mild cognitive impairment, dementia and the risk of
developing Alzheimer's disease.
Physical exercise
People in the early stages of Alzheimer's disease who are more physically
fit have less shrinkage in areas of the brain that are important for memory.
Fitness and exercise slow age-related changes in the brain in healthy people.
People with early Alzheimer's disease are likely to benefit by exercising.
Nursing home residents with Alzheimer's disease who participate in a moderate exercise program have a significantly slower deterioration than those who receive routine medical care.
Causes
People with high levels of inflammatory markers are more likely to develop this
neural degenerative condition than those who do not. Men are much less likely
than women to live into their 90s, but those who do have a much lower chance of
having Alzheimer's disease or another form of dementia.
Family history as risk
factor
If both parents have Alzheimer's disease, a person is more likely than
other people to get it.
Pesticides, environmental
toxins, pollutants as possible causative agents
Exposure to pesticides may have long-term effects on the nervous system,
increasing the risk of Alzheimer’s disease in late life.
Atrial fibrillation as cause
Dr. T. Jared Bunch of the Intermountain Medical Center in Murray, Utah, was
quoted at "Heart Rhythm 2009" -- the annual scientific sessions of the Heart
Rhythm Society in Boston, "There has always been a known association between
atrial fibrillation and vascular dementia related to stroke. What is less known
is the association between atrial fibrillation and other dementias, like
Alzheimer's disease." Dr. T. Jared Bunch followed 37,000 patients with a mean
age of 60 years, Twenty seven percent developed atrial fibrillation and 4%
developed dementia during a five-year follow-up period. Patients with dementia
were older and had higher rates of hypertension, coronary heart disease, renal
failure, heart failure and prior strokes. Atrial fibrillation was strongly and
independently associated with all forms of dementia, including Alzheimer's
disease. Patients with atrial fibrillation were much more likely to develop
dementia than those without.
Symptoms
There are several symptoms common to Alzheimer disease patients. They include: trouble remembering things...at first, only short-term memory
may be affected. The individual may forget an appointment or the name of a new
acquaintance. A person may also forget where they left things. Eventually,
long-term memory is also impaired. An inability to correctly identify familiar
odors may be an early indication of the onset of Alzheimer's disease.
Alzheimer disease symptoms include mood or personality changes. A person may
suddenly become angry or sad for no apparent reason. Or someone who was social
and outgoing may become withdrawn.
Trouble completing ordinary tasks is another symptom of
Alzheimer's disease. Simple tasks that once caused no difficulty may become much
more challenging. For example, the individual may forget how to dress, use the
oven, etc.
Others include difficulty expressing thoughts and disorientation. We
all know what it's like to be driving and momentarily forget where you are
going. But those with AD may get lost in their neighborhood.
They may also lose track of dates and the time.
Unusual behavior. The individual may wander, become
agitated, hide things, wear too few or too many clothes, become overly
suspicious, or engage in unsafe behaviors.
Characteristic of brain tissue
Alzheimer's dementia is
characterized by widespread neuronal loss, beta-amyloid deposits in the cerebral blood
vessels, development of neuritic plaques and the presence of neurofibrillary tangles.
These changes, occurring in the association area of the cerebral cortex, the hippocampus
and the middle and temporal lobes, are accompanied by decreased concentrations of the
neurotransmitter acetylcholine. Recent US census figures
suggest that by 2050, the number of people with AD will triple.
Pharmaceutical drug therapy
Cholinesterase inhibitors such as donepezil, rivastigmine,
and galantamine are
often used but they do not provide a cure or long term solution.
Celecoxib or naproxen medication use does not prevent the onset of
Alzheimer dementia, at least within the early years after initiation of
treatment. Celecoxib 200 mg bid does not slow the progression and the occurrence of adverse events is expected
to be high for an elderly
population with complex chronic medical conditions.
Medicines most commonly prescribed for agitation and delusions in Alzheimer’s disease are not effective and put the patients at risk of serious adverse effects, including confusion, sleepiness and Parkinson’s disease-like symptoms. The drugs tested in the study, Zyprexa from Eli Lilly; Seroquel from AstraZeneca; and Risperdal from Janssen Pharmaceutical, belong to a class of medications known as atypical antipsychotics. These drugs are used to treat schizophrenia and other psychoses, and are commonly prescribed for elderly patients in long-term care facilities. About a third of the estimated 2.5 million Medicare beneficiaries in nursing homes in the United States have taken the medications. Memantine, sold as Namenda in the U.S. is not effective.
Drugs for Alzheimer's dementia, which pharmaceutical companies and campaigners have lobbied the UK government to provide to large numbers of elderly patients with dementia across the country have little effect on their memory and do not stop the distressing deterioration of their lives,. The five-year study, paid for by the NHS, found that the drugs are a waste of the scarce resources available for the condition.